Back to top
more

Phibro Animal Health (PAHC)

(Real Time Quote from BATS)

$21.74 USD

21.74
28,561

-0.54 (-2.42%)

Updated Sep 23, 2024 10:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 25% (63 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Why Is Phibro (PAHC) Down 10.9% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Phibro (PAHC) Sales Impacted by Macro Concerns, FX Headwind

The COVID-19 pandemic has adversely affected the international economic conditions and financial markets, leading to an economic downturn in many countries, in which Phibro (PAHC) operates.

Phibro (PAHC) Q4 Earnings Miss Estimates, Gross Margin Falls

Robust performance across the Animal Health segment is encouraging for Phirbo (PAHC).

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Medtronic (MDT) Surpasses Q1 Earnings and Revenue Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 8.11% and 1.71%, respectively, for the quarter ended July 2023. Do the numbers hold clues to what lies ahead for the stock?

Phibro's (PAHC) Sales Hurt by Rising Costs, FX Headwind

Phibro (PAHC) input costs continue to be high as a result of sustained inflation.

Apyx Medical (APYX) Reports Q2 Loss, Misses Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of 8.33% and 4.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Top Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of 45.45% and 3.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Tops Revenue Estimates

Agios Pharmaceuticals (AGIO) delivered earnings and revenue surprises of 5.63% and 0.63%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Should Value Investors Buy Phibro Animal Health (PAHC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why Investors Should Retain Phibro (PAHC) for Now

Investors are optimistic about Phibro's (PAHC) diversified offerings and booming vaccine business.

Phibro (PAHC) Q3 Earnings Miss Estimates, Gross Margin Up

Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.

Phibro Animal Health (PAHC) Q3 Earnings Lag Estimates

Phibro (PAHC) delivered earnings and revenue surprises of -12.12% and 0.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Phibro (PAHC) Q2 Earnings Top Estimates, Gross Margin Up

Growing uptake of MFAs, dairy products and vaccines contributed to Phibro's (PAHC) Q2 revenues.

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Beat Estimates

Phibro (PAHC) delivered earnings and revenue surprises of 13.33% and 2.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Baxter International (BAX) Q4 Earnings Expected to Decline

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Phibro Animal Health (PAHC) to Report a Decline in Earnings: What to Look Out for

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for Phibro (PAHC) Stock Options

Investors need to pay close attention to Phibro (PAHC) stock based on the movements in the options market lately.

Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass

Phibro's (PAHC) growing uptake of MFAs, dairy products and vaccines buoys optimism.

Phibro Animal Health (PAHC) Misses Q1 Earnings Estimates

Phibro (PAHC) delivered earnings and revenue surprises of -19.23% and 3.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Greenbrook TMS Inc. (GBNH) Reports Q3 Loss, Tops Revenue Estimates

Greenbrook TMS Inc. (GBNH) delivered earnings and revenue surprises of -131.82% and 14.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Phibro (PAHC) Down 18.4% Since Last Earnings Report: Can It Rebound?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AdaptHealth Corp. (AHCO) Stock Jumps 5.2%: Will It Continue to Soar?

AdaptHealth Corp. (AHCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Phirbo (PAHC) Faces Rising Costs and Inflationary Pressure

Price competition coming from cheap generic alternatives of a few Phirbo (PAHC) products is a deterrent.